SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,904.78 -73.14
(-0.15%)

Dow Jones

6,863.50 -36.75
(-0.53%)

Hang Seng

56,282.78 -1,774.46
(-3.06%)

Nikkei 225

10,782.87 -127.68
(-1.17%)

Forex

USD-INR

91.06 0.13
(0.14%)

EUR-INR

107.55 0.22
(0.20%)

GBP-INR

122.70 -0.27
(-0.22%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

62.7662681

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

13.76

119.18

EPS(TTM)

Face Value()

Div & Yield %

5.44

1.6

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	302.50	338.54	303.10	280.37	249.31	170.67
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	302.50	338.54	303.10	280.37	249.31	170.67
Other Income	2.15	2.30	2.19	6.49	2.69	3.63
Stock Adjustments	7.08	1.06	17.90	4.85	-5.13	-3.32
Total Income	311.73	341.90	323.19	291.71	246.87	170.98
EXPENDITURE :
Raw Materials	164.85	192.80	187.83	171.35	145.45	81.39
Power & Fuel Cost	8.29	8.73	6.87	5.37	4.70	4.68
Employee Cost	61.83	59.57	51.56	44.46	39.62	48.78
Other Manufacturing Expenses	10.70	12.95	20.20	14.64	9.12	7.07
Selling & Administrative Expenses	33.21	32.27	26.21	21.64	15.44	17.59
Miscellaneous Expenses	0.42	1.56	1.90	4.35	3.24	0.82
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	279.30	307.89	294.56	261.82	217.57	160.34
Operating Profit	32.42	34.01	28.62	29.89	29.30	10.64
Interest	17.04	14.64	12.59	10.60	12.25	12.69
Gross Profit	15.38	19.37	16.03	19.29	17.05	-2.05
Depreciation	9.65	10.05	7.48	7.24	7.26	7.03
Profit Before Tax	5.73	9.32	8.55	12.05	9.79	-9.08
Tax	-0.14	0.76	2.03	5.42	0.38	-0.15
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.93	0.84	0.39	-1.94	0.32	-0.03
Reported Net Profit	7.80	7.73	6.13	8.58	9.10	-8.90
Extraordinary Items	0.00	0.05	0.03	0.78	0.04	0.00
Adjusted Net Profit	7.80	7.68	6.10	7.80	9.06	-8.90
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-0.29
P & L Balance brought forward	42.90	36.74	42.37	35.27	26.18	36.79
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.91	1.57	1.56	1.48	0.00	1.42
P & L Balance carried down	48.79	42.90	46.94	42.37	35.27	26.17
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	12.00	12.00	10.00	10.00	10.00	0.00
Dividend Per Share(Rs)	1.20	1.20	1.00	1.00	1.00	0.00
Earnings Per Share-Unit Curr	4.90	4.89	3.90	5.79	6.14	-6.28
Earnings Per Share(Adj)-Unit Curr	4.90	4.89	3.90	5.79	6.14	-6.28
Book Value-Unit Curr	62.07	58.74	61.21	58.28	52.88	46.53
Book Value(Adj)-Unit Curr	62.07	58.74	61.21	58.28	52.88	46.53

80,238.85 -1,048.34 ( -1.29%)

48,904.78 -73.14 (-0.15%)

6,863.50 -36.75 (-0.53%)

56,282.78 -1,774.46 (-3.06%)

10,782.87 -127.68 (-1.17%)

91.06 0.13 (0.14%)

107.55 0.22 (0.20%)

122.70 -0.27 (-0.22%)

0.58 0.00 (0.12%)